- Home
- GSIW vs AEON Comparison
GSIW vs AEON Comparison
Compare GSIW & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GSIW | AEON |
|---|---|---|
| Founded | 2016 | N/A |
| Country | Hong Kong | United States |
| Employees | N/A | 5 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5M | 26.8M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | GSIW | AEON |
|---|---|---|
| Price | $30.30 | $1.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.20 |
| AVG Volume (30 Days) | 3.6K | ★ 140.7K |
| Earning Date | 08-04-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.05 | $0.38 |
| 52 Week High | $36.90 | $1.45 |
Technical Indicators
Market Signals| Indicator | GSIW | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 82.72 | 55.85 |
| Support Level | $0.11 | $0.98 |
| Resistance Level | $36.90 | $1.12 |
| Average True Range (ATR) | 1.43 | 0.09 |
| MACD | 0.80 | 0.02 |
| Stochastic Oscillator | 95.57 | 63.79 |
Price Performance
Historical ComparisonAbout GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.